Vietnam has completed the first phase of the human trials of Nano Covax. (Photo: VNA)
Hanoi (VNA) – Vietnam has completed the
first phase of the human trials of Nano Covax, a homegrown vaccine,
with the participation of 60 volunteers, the Vietnam Military Medical
University said on February 8.
The last 22 volunteers received the second shots, with
two receiving the 50mgc dose, and 20 getting the 75mgc dose.
Experts said has proven safe and effective against
the coronavirus SARS-CoV-2, even its new variant.
Most of the volunteers are in stable conditions after vaccination.
Only few had light injection site pain and fever that disappeared after one to two
days.
The objective of the first phase is to evaluate the
safety of the vaccine, developed and manufactured by HCM City-based Nanogen
Pharmaceutical Biotechnology JSC.
Nearly 400 people have registered for the second phase
that is expected to last for six months, during which 560 volunteers will be
injected.
The third phase will see the engagement of more than 10,000
volunteers, beginning from August.
If the result is good, Vietnam would administer the
vaccine to the public in early 2022./.
Source: VietnamPlus
